UBS Reiterates Buy Rating on Thermo Fisher Scientific (TMO) on Solid Quarter

UBS analyst Douglas Schenkel reiterated a Buy rating and $800.00 price target on Thermo Fisher Scientific (NYSE: TMO).

The analyst commented, "This was a solid quarter - Q3 revenue beat on organic growth (6% vs. Street 4.2%) and EPS ($6.68 vs. $6.40). There are some Q/Q timing dynamics; that said '26 >'25, H2 > H1, and momentum continues into and '27 and beyond. The portfolio is attractive and TMO is positioning/investing for outsized growth vs. peers. Reiterate BUY rating and $800 Price Target."

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $694.02 yesterday.

You May Also Be Interested In

• Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
• Northrop Grumman wins $43.8M Navy contract for Trident II facility
• Therma Bright plans $420,000 non-brokered private placement